Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglycemic Agents | 5 | 2019 | 3081 | 0.710 |
Why?
|
| Republic of Korea | 12 | 2021 | 571 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2024 | 12143 | 0.590 |
Why?
|
| Sulfonylurea Compounds | 1 | 2019 | 219 | 0.580 |
Why?
|
| Glucagon-Like Peptides | 1 | 2018 | 153 | 0.570 |
Why?
|
| Fatty Liver | 3 | 2017 | 789 | 0.540 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 311 | 0.480 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 612 | 0.400 |
Why?
|
| Metformin | 1 | 2019 | 906 | 0.380 |
Why?
|
| Life Expectancy | 1 | 2017 | 1242 | 0.360 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 1474 | 0.330 |
Why?
|
| Obesity | 4 | 2019 | 12938 | 0.290 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 15498 | 0.290 |
Why?
|
| Coronary Vessels | 3 | 2018 | 3096 | 0.290 |
Why?
|
| Coronary Artery Disease | 5 | 2018 | 6395 | 0.280 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2110 | 0.260 |
Why?
|
| Waist Circumference | 4 | 2019 | 934 | 0.200 |
Why?
|
| Sex Distribution | 2 | 2017 | 2281 | 0.190 |
Why?
|
| Adiponectin | 3 | 2018 | 1113 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2015 | 598 | 0.190 |
Why?
|
| Age Distribution | 2 | 2017 | 2880 | 0.190 |
Why?
|
| Hypertension | 2 | 2018 | 8542 | 0.170 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2016 | 144 | 0.160 |
Why?
|
| Middle Aged | 26 | 2021 | 220826 | 0.150 |
Why?
|
| Glucosamine 6-Phosphate N-Acetyltransferase | 1 | 2017 | 1 | 0.150 |
Why?
|
| Endothelial Cells | 3 | 2015 | 3541 | 0.150 |
Why?
|
| Atherosclerosis | 4 | 2018 | 3407 | 0.150 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2017 | 30 | 0.150 |
Why?
|
| Plasmalogens | 1 | 2017 | 30 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2015 | 2208 | 0.140 |
Why?
|
| Risk Factors | 14 | 2021 | 74167 | 0.140 |
Why?
|
| Incidence | 8 | 2019 | 21341 | 0.140 |
Why?
|
| Korea | 1 | 2016 | 98 | 0.130 |
Why?
|
| Male | 31 | 2024 | 360736 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2015 | 2488 | 0.130 |
Why?
|
| Aged | 19 | 2024 | 169235 | 0.130 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12456 | 0.120 |
Why?
|
| Disease Progression | 5 | 2021 | 13502 | 0.120 |
Why?
|
| Neoplasms | 4 | 2017 | 22164 | 0.120 |
Why?
|
| Hypertriglyceridemia | 1 | 2018 | 293 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2015 | 85 | 0.120 |
Why?
|
| Metabolism | 1 | 2016 | 193 | 0.120 |
Why?
|
| Female | 29 | 2024 | 392581 | 0.120 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 374 | 0.120 |
Why?
|
| Sex Factors | 3 | 2018 | 10548 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2018 | 461 | 0.120 |
Why?
|
| Glucosides | 1 | 2019 | 512 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2018 | 633 | 0.120 |
Why?
|
| Linoleic Acid | 1 | 2015 | 158 | 0.110 |
Why?
|
| Dehydroepiandrosterone | 1 | 2015 | 258 | 0.110 |
Why?
|
| Vasodilation | 1 | 2018 | 961 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 549 | 0.110 |
Why?
|
| Rural Health | 1 | 2015 | 297 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 1703 | 0.110 |
Why?
|
| Body Mass Index | 7 | 2021 | 12951 | 0.110 |
Why?
|
| Urban Health | 1 | 2015 | 533 | 0.100 |
Why?
|
| Reference Values | 2 | 2017 | 4921 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2019 | 916 | 0.100 |
Why?
|
| Serpins | 1 | 2014 | 247 | 0.100 |
Why?
|
| Health Surveys | 3 | 2019 | 4059 | 0.100 |
Why?
|
| Phenotype | 4 | 2019 | 16606 | 0.100 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6309 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2019 | 884 | 0.100 |
Why?
|
| Bilirubin | 1 | 2013 | 436 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1096 | 0.100 |
Why?
|
| Body Weight | 2 | 2019 | 4618 | 0.100 |
Why?
|
| Adult | 18 | 2019 | 221148 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2016 | 3244 | 0.090 |
Why?
|
| Blood Glucose | 4 | 2019 | 6391 | 0.090 |
Why?
|
| American Heart Association | 1 | 2015 | 1045 | 0.090 |
Why?
|
| Humans | 33 | 2024 | 761423 | 0.090 |
Why?
|
| Patient Preference | 1 | 2017 | 924 | 0.080 |
Why?
|
| Cytokines | 2 | 2015 | 7392 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 1141 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7389 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1600 | 0.070 |
Why?
|
| Prognosis | 3 | 2017 | 29620 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2024 | 64651 | 0.070 |
Why?
|
| Adiposity | 1 | 2017 | 1877 | 0.070 |
Why?
|
| Autophagy | 1 | 2015 | 1326 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2017 | 23990 | 0.070 |
Why?
|
| Comorbidity | 2 | 2021 | 10498 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2243 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2009 | 604 | 0.070 |
Why?
|
| Family | 1 | 2017 | 3197 | 0.070 |
Why?
|
| Age Factors | 3 | 2019 | 18400 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3204 | 0.070 |
Why?
|
| Ankle Brachial Index | 2 | 2018 | 163 | 0.060 |
Why?
|
| Cause of Death | 1 | 2016 | 3684 | 0.060 |
Why?
|
| Perception | 1 | 2012 | 1197 | 0.060 |
Why?
|
| Nerve Fibers | 1 | 2009 | 708 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39117 | 0.060 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2015 | 44 | 0.060 |
Why?
|
| Caregivers | 1 | 2017 | 2237 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2018 | 441 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 10203 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10089 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 58956 | 0.060 |
Why?
|
| Models, Biological | 2 | 2017 | 9469 | 0.060 |
Why?
|
| Liver | 1 | 2019 | 7532 | 0.050 |
Why?
|
| Insulin | 1 | 2018 | 6602 | 0.050 |
Why?
|
| Social Support | 1 | 2012 | 2172 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7956 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12058 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 41446 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5840 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7856 | 0.050 |
Why?
|
| Cholesterol, HDL | 2 | 2018 | 1814 | 0.040 |
Why?
|
| Registries | 1 | 2016 | 8223 | 0.040 |
Why?
|
| Young Adult | 5 | 2019 | 59207 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15838 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2176 | 0.040 |
Why?
|
| Prevalence | 3 | 2019 | 15717 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 39975 | 0.040 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2018 | 89 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 619 | 0.040 |
Why?
|
| Triglycerides | 2 | 2016 | 2460 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11458 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 190 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2018 | 8320 | 0.030 |
Why?
|
| Logistic Models | 2 | 2021 | 13255 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 587 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 9756 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2018 | 704 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10762 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1179 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 193 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2016 | 416 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 14599 | 0.030 |
Why?
|
| Coronary Angiography | 2 | 2016 | 4472 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 574 | 0.030 |
Why?
|
| Phagosomes | 1 | 2015 | 199 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 603 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 605 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.030 |
Why?
|
| Risk | 2 | 2015 | 9612 | 0.030 |
Why?
|
| Health Status | 2 | 2019 | 4075 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2394 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 8122 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1626 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2015 | 421 | 0.020 |
Why?
|
| Fasting | 1 | 2018 | 1602 | 0.020 |
Why?
|
| Health | 1 | 2014 | 398 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 7825 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 13361 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2018 | 18964 | 0.020 |
Why?
|
| Anthropometry | 1 | 2014 | 1349 | 0.020 |
Why?
|
| Lysosomes | 1 | 2015 | 923 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2455 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2133 | 0.020 |
Why?
|
| Indoles | 1 | 2017 | 1832 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3418 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2017 | 6231 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1486 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3340 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2019 | 80582 | 0.020 |
Why?
|
| Aorta | 1 | 2015 | 2041 | 0.020 |
Why?
|
| Weight Loss | 1 | 2019 | 2683 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2898 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8179 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 2382 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5970 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2015 | 1459 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6479 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3823 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26112 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11073 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2017 | 23441 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10766 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4347 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6343 | 0.010 |
Why?
|
| Asthma | 1 | 2021 | 6211 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14664 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14409 | 0.010 |
Why?
|
| Kidney | 1 | 2015 | 7049 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3963 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16979 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22163 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18247 | 0.010 |
Why?
|
| Mental Health | 1 | 2012 | 3249 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11902 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4477 | 0.010 |
Why?
|
| Heart Failure | 1 | 2021 | 11674 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13337 | 0.010 |
Why?
|
| Animals | 2 | 2018 | 168441 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20556 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 54415 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81509 | 0.010 |
Why?
|
| United States | 1 | 2015 | 72339 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_